---All---
  • ---All---
  • Accession
  • Catalog #

PBK Antibody (C-term C300) Blocking PeptideSynthetic peptide

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
BP7164e 0.1 mg 400 ul In Stock $ 45.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

PBK Antibody (C-term C300) Blocking Peptide - Product info

Primary AccessionQ96KB5
Clone Names6071560
Calculated MW36085 Da

PBK Antibody (C-term C300) Blocking Peptide - Additional info

Gene ID 55872
Target/Specificity
The synthetic peptide sequence used to generate the antibody AP7164e was selected from the C-term region of human PBK. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Format
Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
Precautions
This product is for research use only. Not for use in diagnostic or therapeutic procedures.

PBK Antibody (C-term C300) Blocking Peptide - Protein Information

Name PBK
Synonyms TOPK
Function
Phosphorylates MAP kinase p38. Seems to be active only in mitosis. May also play a role in the activation of lymphoid cells. When phosphorylated, forms a complex with TP53, leading to TP53 destabilization and attenuation of G2/M checkpoint during doxorubicin-induced DNA damage
Tissue Location
Expressed in the testis and placenta. In the testis, restrictedly expressed in outer cell layer of seminiferous tubules

PBK Antibody (C-term C300) Blocking Peptide - Related products

AP3577a: Phospho-PBK-pY74 Antibody

AP3633a: Phospho-PBK-pT9 Antibody

AP7164a: PBK Antibody (N-term)

AP7164b: PBK Antibody (C-term)

AP7164d: PBK Antibody (N-term N6)

AP7164e: PBK Antibody (C-term C300)

AP7164f: PBK Antibody (Y74)

RI13823: PBK predesign siRNA

BP3577a: Phospho-PBK-pY74 Antibody Blocking Peptide

BP3633a: Phospho-PBK-pT9 Antibody Blocking Peptide

BP7164a: PBK Antibody (N-term) Blocking Peptide

BP7164b: PBK Antibody (C-term) Blocking Peptide

BP7164d: PBK Antibody (N-term N6) Blocking Peptide

BP7164e: PBK Antibody (C-term C300) Blocking Peptide

BP7164f: PBK Antibody (Y74) Blocking Peptide

AT3196a: PBK Antibody (monoclonal) (M06)

AT3197a: PBK Antibody (monoclonal) (M07)

AT3198a: PBK Antibody (monoclonal) (M11)

AT3199a: PBK Antibody (monoclonal) (M12)

AJ1593a: PBK (TOPK) Antibody

AJ1593b: PBK (TOPK) Antibody (C-term)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

PBK is a serine/threonine kinase related to the dual specific mitogen-activated protein kinase kinase (MAPKK) family. Evidence suggests that mitotic phosphorylation is required for its catalytic activity. This mitotic kinase may be involved in the activation of lymphoid cells and support testicular functions, with a suggested role in the process of spermatogenesis.

REFERENCES

Nandi, A., et al., Blood Cells Mol. Dis. 32(1):240-245 (2004).Simons-Evelyn, M., et al., Blood Cells Mol. Dis. 27(5):825-829 (2001).Zhao, S., et al., Int. J. Biochem. Cell Biol. 33(6):631-636 (2001).Abe, Y., et al., J. Biol. Chem. 275(28):21525-21531 (2000).Gaudet, S., et al., Proc. Natl. Acad. Sci. U.S.A. 97(10):5167-5172 (2000).